Medical University Of Vienna — Sponsor Intelligence | 83 EU Trials

Filter these 83 trials by condition, phase, country and more.

Open in Search →

83 Registered trials

57 Recruiting

12 Completed trials

12 Countries active

119 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase I (Other)

Phase III: 4 Phase II: 29 Phase I/II: 2 Phase III/IV: 3 Phase IV: 22 Phase I: 4 Phase I (Other): 19

100%

12 of 12 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Antidepressant therapy 2 Anhedonia 2 Ejection fraction normal 1 Polymyalgia rheumatica 1 Sinus rhythm 1 Acute graft versus host disease in skin 1 Aortic disorder 1 Dermatomyositis 1 Negative symptoms in schizophrenia 1 Schizoaffective disorder depressive type 1 Antisynthetase syndrome 1 Immune-mediated myositis 1

Top IMPs

DUPILUMAB 4 CEFAZOLIN 3 ESKETAMINE HYDROCHLORIDE 3 LANDIOLOL HYDROCHLORIDE 3 PROPOFOL 3 SODIUM CHLORIDE 3 AMPICILLIN SODIUM 2 BEVACIZUMAB 2 CEFUROXIME SODIUM 2 GENTAMICIN 2 GOZETOTIDE 2 HEPARIN SODIUM 2

All trials — page 3

83 total

Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients Recruiting

2024-518226-32-00 Phase IV 1 country BUPROPION HYDROCHLORIDE; ESCITALOPRAM OXALATE
Antibiotic pharmacokinetics in women with twin pregnancy Recruiting

2024-518564-12-00 Phase IV 1 country AMPICILLIN SODIUM; CEFAZOLIN; CLINDAMYCIN; PIPERACILLIN, TAZOBACTAM
A prospective, single-center phase I pilot study to assess the tissue activity of multidrug resistance-associated protein 1 with positron em… Recruiting

2024-517851-11-00 Phase I 1 country
Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial Recruiting

2024-518212-40-00 Phase III 1 country KETAMINE; MIDAZOLAM HYDROCHLORIDE
Ketamine study Recruiting

2024-519097-39-01 Phase III 1 country DIPHENHYDRAMINE HYDROCHLORIDE; ESKETAMINE HYDROCHLORIDE
InvestiGating the rOle of Growth Hormone in hepatic lipid metabolism in humans Recruiting

2024-518214-11-01 Phase II 1 country PEGVISOMANT; SOMATROPIN
LANDI-POAF study Recruiting

2024-518950-17-00 Phase III 1 country LANDIOLOL HYDROCHLORIDE
Examination of medication-induced skin inflammation models and their use in the study of antibiotic concentration in inflamed, infected, and… Recruiting

2024-518477-34-00 Phase I (Other) 1 country
Felzartamab in late ABMR Recruiting

2024-511764-86-00 Phase II 2 countries
VitDM3BH Study Recruiting

2024-518897-15-00 Phase II 1 country
Beta-blockade in cardiac arrest Recruiting

2024-518949-14-00 Phase II 1 country LANDIOLOL HYDROCHLORIDE; SODIUM CHLORIDE
Treatment of neovascular AMD: Artificial intelligence in real-world setting Recruiting

2024-518482-99-01 Phase IV 1 country AFLIBERCEPT; BROLUCIZUMAB; RANIBIZUMAB
Epiflux Recruiting

2024-515540-23-00 Phase II 1 country
Pharmacokinetics of antibiotics in bile fluid of patients with external biliary drainage Recruiting

2024-517165-17-00 Phase I (Other) 1 country
Investigation of neurobiological mechanisms of antidepressant action of ketamine using neuroimaging Recruiting

2024-519234-23-00 Phase I (Other) 1 country ESKETAMINE HYDROCHLORIDE; KETAMINE HYDROCHLORIDE; SODIUM CHLORIDE
Studying the effects of intramuscular testosterone supplementation compared with placebo on liver fat content in obese men with low testoste… Recruiting

2023-509819-87-00 Phase IV 1 country TESTOSTERONE UNDECANOATE
Single dose pharmacokinetics of selective serotonin reuptake inhibitor sertraline in plasma of female anorexia nervosa patients and healthy… Recruiting

2024-512830-13-00 Phase I (Other) 1 country
Pharmacokinetics of antibiotics in cerebrospinal fluid of children with malignant brain tumors – a pilot study Recruiting

2024-518808-43-00 Phase I 1 country AMOXICILLIN, CLAVULANIC ACID; CEFOTAXIME SODIUM; CEFTRIAXONE SODIUM; CEFUROXIME …
Pharmacokinetics of a novel extended infusion regimen of fosfomycin Recruiting

2024-512681-34-00 Phase I (Other) 1 country
A pilot study to assess the impact of ABCB1 on the neuropharmacokinetics of the weak ABCB1 substrate [11C]metoclopramide Recruiting

2024-517875-19-00 Phase I 1 country
Investigating How Anti-Infection Drugs Are Processed in the Bodies of Healthy People and Severely Burned Patients in the Intensive Care Unit Recruiting

2024-517260-39-00 Phase I (Other) 1 country
A pilot study to assess the influence of drug transporters on brain and organ distribution of erlotinib in humans Recruiting

2024-516550-21-00 Phase I 1 country
MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting

2024-515626-92-00 Phase II 7 countries BEVACIZUMAB; CELECOXIB; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FENOFIBRATE; IR…
A prospective randomized, single blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital an… Ended

2024-512210-18-00 Phase III/IV 1 country ESKETAMINE HYDROCHLORIDE; METHOHEXITAL SODIUM; PROPOFOL

Showing 49–72 of 83 trials

← All sponsors A–Z